|
| ID |
DDInter631 |
| Drug Type |
small molecule |
| Molecular Formula |
C25H22N4O4 |
| Molecular Weight |
442.475
|
| Description |
Eltrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies.
|
| ATC Classification |
B02BX05
|
| IUPAC Name |
3'-{2-[(4Z)-1-(3,4-Dimethylphenyl)-3-Methyl-5-Oxo-4,5-Dihydro-1H-Pyrazol-4-Ylidene]Hydrazin-1-Yl}-2'-Hydroxy-[1,1'-Biphenyl]-3-C |
| InChI |
Inchi=1S/C25H22N4O4/C1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/H4-13,26,30H,1-3H3,(H,32,33)/B27-22- |
| InChI Key |
XDXWLKQMMKQXPV-QYQHSDTDSA-N |
| Canonical SMILES |
CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|